Clinical Trials Browser

Phase 1 × Lymphoid Malignancy × navitoclax × Clear all

NCT00982566 2017-11-21

Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer

Phase 1 Completed

Other solid neoplasm

Lymphoid Malignancy